
Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Ovarian Cancer Issue
Oncology Today with Dr Neil Love
00:00
The Importance of Risk Reduction in Breast Cancer
In stage 2, there's really no debate about a stage 2 patients being offered. Stage 1 is much more unclear to me; I'm having to have that conversation come with a shared decision. Ohio State has had to change practices and reserve the platinum base therapy for those who are curative intent. But we also want to reserve our patients who have been shown to have overall survival intent even if they're not curative.
Transcript
Play full episode